EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Eupraxia Pharmaceuticals (EPRX) was upgraded by Wall Street Zen from
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences [Canadian Business Journal (Canada)]
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
Eupraxia Pharmaceuticals (EPRX) is now covered by William Blair. They set an "outperform" rating on the stock.
Eupraxia Pharmaceuticals (EPRX) was downgraded by Zacks Research from "hold" to "strong sell".
Form 6-K EUPRAXIA PHARMACEUTICALS For: Apr 14
Form 6-K EUPRAXIA PHARMACEUTICALS For: Apr 14
Form 6-K EUPRAXIA PHARMACEUTICALS For: Mar 17
Form SCHEDULE 13D/A EUPRAXIA PHARMACEUTICALS Filed by: Freedman Joseph S.
Form 40-F EUPRAXIA PHARMACEUTICALS For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.